Loeffler’s Syndrome Induced by the Transmigration of Strongyloides stercoralis to the Lungs: A Case Report and Literature Review.

Publication date: Dec 01, 2024

Loeffler’s syndrome is a rare, benign respiratory disease usually associated with peripheral eosinophilia, first described by Wilhelm Loeffler in 1932. It is caused by the larvae of helminths such as hookworms, Ascaris, and Strongyloides that transmigrate through the lungs during the active phase of infection. We present a case of a 53-year-old man who complained of a productive cough with intermittent hemoptysis and left-sided posterior chest pain. Initial evaluation revealed ground-glass opacity in the left upper lobe on chest X-ray and computed tomography (CT) scan, with laboratory results suggestive of leukocytosis, eosinophilia, and elevated IgE levels. After ruling out other potential diagnoses, strongyloidiasis was suspected. Serology for Strongyloides stercoralis was positive, and stool studies confirmed the presence of Strongyloides larvae. The patient was started on ivermectin and followed up in the outpatient clinic. Repeat chest CT after one month showed resolution of the previously noted left upper lobe infiltrate. This case report aims to describe this rare instance of Loeffler’s syndrome and provide an update on the epidemiology, risk factors, and association of strongyloidiasis with other diseases and medications.

Open Access PDF

Concepts Keywords
Hookworms autoinfection
Leukocytosis covid-19
Productive ivermectin and albendazole
Tomography loeffler’s syndrome
Wilhelm parasitic infections
peripheral eosinophilia
strongyloides stercoralis
transmigration

Semantics

Type Source Name
disease MESH Syndrome
disease MESH eosinophilia
disease MESH infection
disease MESH chest pain
disease MESH leukocytosis
disease MESH strongyloidiasis
drug DRUGBANK Ivermectin
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Allergy
disease MESH Infectious Disease
pathway REACTOME Infectious disease
disease MESH covid 19
drug DRUGBANK Albendazole
disease MESH parasitic infections
disease MESH pulmonary diseases
disease MESH simple pulmonary eosinophilia
disease MESH asthma
pathway KEGG Asthma
disease MESH polyarteritis nodosa
disease MESH emergency
drug DRUGBANK Acetaminophen
disease IDO history
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH seizures
disease MESH syncope
drug DRUGBANK Oxygen
drug DRUGBANK Medical air
disease IDO blood
disease MESH abnormalities
disease IDO assay
disease MESH pneumonia
disease MESH fungal infection
drug DRUGBANK Rifampicin
disease MESH hypersensitivity pneumonitis
drug DRUGBANK Potassium
drug DRUGBANK Chloride ion
drug DRUGBANK Creatinine
drug DRUGBANK Calcium
drug DRUGBANK Phosphorus
disease IDO cell
disease IDO immunodeficiency
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
disease MESH pleural effusion
disease MESH person to person transmission
disease MESH diverticulosis
drug DRUGBANK Azathioprine
drug DRUGBANK Cyclophosphamide
drug DRUGBANK Doxorubicin
drug DRUGBANK Daunorubicin
drug DRUGBANK Ifosfamide
drug DRUGBANK Chlorambucil
drug DRUGBANK Methotrexate
drug DRUGBANK Bleomycin
drug DRUGBANK Melphalan
drug DRUGBANK Carmustine
drug DRUGBANK Mitoxantrone
disease MESH allergic rhinitis
disease IDO immunosuppression
disease MESH hypogammaglobulinemia
disease MESH nephrotic syndrome
disease MESH multiple myeloma
disease MESH primary immune deficiencies
drug DRUGBANK Ethanol
disease MESH malnutrition
drug DRUGBANK Prednisolone
disease MESH septicemia
disease MESH urticaria
disease MESH angioneurotic edema
disease MESH bronchospasm
drug DRUGBANK Dexamethasone
disease MESH dyspnea
disease MESH inflammation
disease MESH choking
disease MESH bacteremia
disease IDO bacteria
disease MESH meningitis
disease MESH bacterial infection
disease IDO facility
disease IDO parasite
disease MESH bleeding
disease MESH death
disease MESH tumor
drug DRUGBANK Lauric Acid
disease MESH co infection
disease MESH HIV infection
pathway REACTOME HIV Infection

Original Article

(Visited 5 times, 1 visits today)